Premium Affron® Saffron ingredient cements leadership position with exclusive rights in mental wellness category
Affron®, Pharmactive Biotech Products, S.L.U.’s premium saffron ingredient, cements its leadership position in the US saffron mental wellness category and continues double-digit growth in the first quarter of 2022 with its unique US granted patent for low mood support.
This patent serves as official recognition of the company’s unique process in the formulation of affron and its ability to assist individuals with low mood related issues.
While saffron has centuries-old recognition for health benefits in traditional medicine, the exceptional efficacy and quality standards of affron have earned it a solid reputation as a /first-rate botanical ingredient. It is also recognised as the most scientifically backed saffron ingredient worldwide thanks to eight published human clinical studies, which included more than 740 participants.
These trials demonstrated affron’s positive effect on multiple aspects of mental well-being and sleep quality, in different target populations, including menopausal women, adults, and for the first time for a commercial extract of saffron, it showed its ability to elevate teens’ spirits. More concretely, the research highlighted affron’s manifold potentials for helping manage low mood, occasional stress, inducing positive feelings, and supporting healthy sleep.
Affron is also pioneer in its proprietary extraction process from saffron stigmas (Crocus sativus L.), which consists of an all-natural and low-energy consumption procedure, called AFF ON Cool-Tech®. This active-saver process is specifically designed to optimize the preservation and concentration of the key active ingredients with minimal industrial processing, without chemicals, and minimal energy use. Furthermore, this extraction technique is based solely on water, resulting in an ingredient that is clean of any solvents or alcohols.
All of the above have made it the most awarded saffron ingredient worldwide, with four accorded international awards; the last and most recent, being the NutraIngredients Europe Award 2022, where affron was declared the winner as the Ingredient of the year: Healthy Ageing. This sums up the exclusive right Pharmactive had earned in the US, for the formulation and use of affron in connection with low mood support, endorsed by the clinical studies and effectively confirmed by the granted patent.
The affron patent essentially protects the proprietary composition and dosages of affron that renders it uniquely effective as a natural mood-support agent. Its recommended daily dose is the lowest in the market – only 28mg- and is standardized to Lepticrosalides®, a proprietary and unique pool of bioactives responsible for affron’s activity, crimson color, and prized organoleptic qualities. This is verified by means of HPLC (high-performance liquid chromatography).
“This innovation activity recognition has greatly supported the sustained growth of our top-notch saffron ingredient in the US, in mental wellness category,” claims Marguerite Gerritsen, Managing Director for Pharmactive.
Gencor is the exclusive distributor of affron in the US and this partnership is key in making this outstanding ingredient available to the North American nutraceutical and food markets.
Innovations in Food (& Beverage) Technology is a quarterly magazine distributed globally both in Print and Digital formats. www.innovationsfood.com. Twitter: @Innovfoodtech. Instagram: @innovationsinfoodtechnology. Linkedin: www.linkedin.com/in/terry-prior52
